Chemesis Advancing Domestically and Internationally, Plus Exclusive CEO Interview
Robin Lefferts
February 6th, 2019
Exclusive, News, Top News
In a cannabis industry that is experiencing explosive growth in multiple and diverse geographical markets, it can be difficult for a business to choose its focus and stay on track. A balance must be achieved between building a presence in a key market and diversifying into new opportunities. With its recent run of deals in California, Colombia, and Puerto Rico, Chemesis International Inc. (CSE: CSI) (OTCQB: CADMF) (FRA: CWAA) appears to be achieving that mix.
In an exclusive interview with CFN Media, Part 1 of 2, CEO Edgar Montero discusses the origins of the company, its operations in California, and the launch of the Jay and Silent Bob’s Private Stash brand of cannabis products.
Click here to receive updates on Chemesis developments.
California is Crucial
The legal rollout in California has been happening in fits and starts as municipalities and the state iron out regulations and process a mountain of applications. Companies working in some of the more forward-thinking locales that were early adopters of the new regulations have a leg up in the legal market. Chemesis falls into this category with its California Sap and Desert Zen operations, located in Cathedral City. The two operations are complementary, with California Sap handling extraction and production of extracts and prerolls, and Desert Zen taking care of packaging and distribution. Both companies handle Chemesis’ own brands while offering contract services to other brands.
With that infrastructure in place, Chemesis has partnered with Jay and Silent Bob to launch the Private Stash brand, based on the characters from the slacker movie classics directed by Kevin Smith. To supercharge the product launch and to enhance sales of its other brands, Chemesis has engaged Dank City, a specialty cannabis marketing firm boasting the largest network of cannabis social media pages. The goal is to leverage Chemesis’ early mover advantage into a comprehensive brand presence throughout the state. With California serving as the world’s largest legal cannabis market and considering the state’s role in setting cultural trends that resonate across the globe, that goal is certainly a worthy one.
Colombia Coming Along Nicely
With the recent acquisition of licensed cultivator La Finca Interactiva-Arachna Med, Chemesis is diving head first into the emerging Latin American market. The company currently grows on 1,060 acres and also operates a 10,000 sqft greenhouse. It also partners with Universidad Nacional of Colombia to research and develop ideal agricultural practices for the cultivation of cannabis. In short, it’s a very early mover in a country that has a fledgling medical marijuana program.
La Finca is commencing construction of a GMP certified extraction and production facility to fill a need for clean and reliable cannabis-derived medicines in the country. By building the operation to the highest standards and working closely with the government every step of the way, Chemesis is ensuring that it can develop a low-cost, high-quality producer with capacity to serve both Colombia and international markets. In the end, the export side of the equation may end up being the largest.
Click here to receive updates on Chemesis developments.
Growth in Puerto Rico
Chemesis has a pattern of developing or acquiring licensed operations in the earliest stages of a developing cannabis market. Its operations in Puerto Rico are no different with its Natural Ventures subsidiary. CEO Edgar Montero and the company played a major role in developing Puerto Rico’s legal medical cannabis regulatory framework, and as a result the company serves about 90% of the island’s dispensaries. Already boasting a 100,000 sqft cultivation facility and a 35,000 sqft extraction facility, Natural Ventures has been adding to its capabilities and product lines significantly over the last couple of months.
In January, Natural Ventures announced the launch of a natural beverages division to include cannabis-derived beverages. Utilizing its current capabilities, and bringing in ingredients like local honey and coffee beans, the company plans an initial launch of beverages designed to provide an energy boost, a calming effect, and sleep support. Infused, functional drinks are one of the fastest growing sectors of the beverage industry and are generally recognized as a major driver in the next wave of development for the cannabis industry.
In another move that ties in with the beverage play while also capitalizing on a high growth sector of the industry, Chemesis announced that it has begun cultivating high CBD strains of hemp on the island. All of the appropriate licenses are in place, from strain registration through cultivation, manufacturing and distribution. With the passage of the 2018 US Farm Bill, it is anticipated that hemp CBD manufacturers will be able to ship products across the US and territories. With the infrastructure in place, and considering Puerto Rico’s favorable climate, Natural Ventures looks to be in a prime position to take advantage of the newly-opening markets for CBD products.
In line with the Puerto Rico CBD developments, Chemesis has also acquired a full line of existing hemp-derived CBD products called Viverian. With existing e-commerce distribution in Arizona, Florida, and Nevada, Chemesis anticipates expanding sales both online and in-store across the US once the state regulations are worked out as a result of the federal Farm Bill. Adding the cultivation and production capacity of its Puerto Rico operations, it’s easy to see the framework of a US-wide CBD operation in the not-too-distant future.
Chemesis is Aligned
By zooming out and taking a macro-view of the Chemesis International operation, the unified plan comes into focus. The company is an early mover in the key markets of California and Colombia, positioned not only to do well in those jurisdictions but to spread out from there as regulations allow. With its foothold secured in Puerto Rico, Chemesis not only serves that emerging market (anticipated to grow to 100,000 registered patients by the end of 2019) but should be able to branch out into other US states with its hemp-based offerings. All of its facilities are built with international best practices in mind, and the company has demonstrated its ability to secure all licenses necessary in each jurisdiction. Keep an eye out as Chemesis builds its operation into an international powerhouse.
Click here to receive updates on Chemesis developments.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Robin Lefferts
Robin Lefferts has been involved in the legal cannabis industry since 2012, sometimes as an active participant and always as an interested observer.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
True Leaf is a Licensed Producer of cannabis preparing to launch a program to provide seed-to-shelf solutions for micro-cultivators.
Zenabis owns 660,000 square feet of high quality indoor facility space, as well as 2.1 million square feet of greenhouse space that will be dedicated to cannabis production once fully built-out.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
